Physician profile
Zachary Smith
NPI 1427376425
$27,378.32
in general payments reported to CMS, 2019-2025
18 companies · $7,828 in 2025
The $7,828 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $8,613 · 2021: $863 · 2022: $8,618 · 2023: $194 · 2024: $561 · 2025: $7,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Consulting Fee: $2,820 · Travel and Lodging: $1,393 · Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Consulting Fee | $2,820.00 |
| Travel and Lodging | $1,393.18 |
| Food and Beverage | $1,369.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,738.22 | 2020-2025 | |
| Angiodynamics, INC. | $3,279.25 | 2024-2025 | Nanoknife |
| Photocure INC | $1,073.86 | 2019-2021 | |
| Urogen Pharma, INC. | $272.38 | 2022-2025 | |
| Baxter Healthcare | $257.55 | 2022-2024 | Perclot, Tisseel |
| Seagen INC. | $162.95 | 2021 | |
| Genzyme Corporation | $122.21 | 2019 | |
| Boston Scientific Corporation | $109.71 | 2020-2024 | Lithovue, Exalt Model D |
| Janssen Scientific Affairs, LLC | $108.79 | 2019 | |
| Astellas Pharma US INC | $93.60 | 2019-2024 | Padcev |
| Civatech Oncology, INC. | $78.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $26.69 | 2022 | |
| Karl Storz Endoscopy-America | $24.68 | 2023 | Hopkins |
| Heron Therapeutics, INC. | $16.39 | 2025 | Aponvie |
| Mimedx Group, INC. | $13.89 | 2025 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.